WAT
NYSE · Life Sciences Tools & Services
Waters Corp
$375.04
+6.17 (+1.67%)
Financial Highlights (FY 2026)
Revenue
5.24B
Net Income
1.06B
Gross Margin
59.2%
Profit Margin
20.3%
Rev Growth
+2.1%
D/E Ratio
0.55
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 59.2% | 59.2% | 45.3% | 45.3% |
| Operating Margin | 25.4% | 22.8% | 18.2% | 16.9% |
| Profit Margin | 20.3% | 19.3% | 14.5% | 11.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.24B | 5.13B | 9.29B | 7.43B |
| Gross Profit | 3.10B | 3.04B | 4.21B | 3.37B |
| Operating Income | 1.33B | 1.17B | 1.69B | 1.25B |
| Net Income | 1.06B | 937.54M | 1.34B | 880.25M |
| Gross Margin | 59.2% | 59.2% | 45.3% | 45.3% |
| Operating Margin | 25.4% | 22.8% | 18.2% | 16.9% |
| Profit Margin | 20.3% | 19.3% | 14.5% | 11.8% |
| Rev Growth | +2.1% | +2.1% | -0.3% | -5.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 6.56B | 6.56B | 4.54B | 5.20B |
| Total Equity | 11.94B | 11.94B | 7.11B | 7.03B |
| D/E Ratio | 0.55 | 0.55 | 0.64 | 0.74 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.41B | 1.31B | 2.41B | 2.08B |
| Free Cash Flow | — | — | 970.87M | 668.96M |